There is no real overlap here — Cadence, Change Healthcare, and Chartboost are large, specialized B2B platforms serving three unrelated industries: chip…
Enterprise licensing sold via direct sales; pricing is not publicly disclosed · From Custom pricing (contact sales); no self-serve or published tiers
Best for: Semiconductor and systems companies that need EDA software for IC, SoC, or PCB design, evaluated against direct competitors like Synopsys and Siemens EDA.
Enterprise / custom quote (B2B healthcare infrastructure, not self-serve SaaS) · From Custom pricing; not publicly listed
Best for: Healthcare payers, providers, and pharmacies that need claims processing and payment connectivity at national scale, now delivered as part of Optum Insight.
Revenue share / programmatic ad platform (not a fixed-fee subscription) · From Free to integrate; monetized via ad revenue share and programmatic bidding
Best for: Mobile game studios that want to monetize inventory through programmatic ad auctions without a fixed subscription fee.
| Cadence Design Systems | Change Healthcare | Chartboost | |
|---|---|---|---|
| Primary category | CRM | CRM | CRM |
| Rating | Not documented | Not documented | Not documented |
| Pricing model | Enterprise licensing sold via direct sales; pricing is not publicly disclosed | Enterprise / custom quote (B2B healthcare infrastructure, not self-serve SaaS) | Revenue share / programmatic ad platform (not a fixed-fee subscription) |
| Starting price | Custom pricing (contact sales); no self-serve or published tiers | Custom pricing; not publicly listed | Free to integrate; monetized via ad revenue share and programmatic bidding |
| Free plan | Not documented | Not documented | Not documented |
| Free trial | Not documented | Not documented | Not documented |
| Platforms | Not documented | Not documented | Not documented |
| Team collaboration | Not documented | Not documented | Not documented |
| AI features | Not documented | Not documented | Not documented |
| Public API | Not documented | Not documented | Not documented |
Three unrelated industries, one shared trait: none publish public pricing
Cadence and Change Healthcare are both sold via direct enterprise sales with pricing not publicly disclosed. Chartboost is technically free to integrate, but it monetizes through revenue share and programmatic bidding rather than a fixed subscription — so none of the three give a buyer a straightforward price to compare.
Cadence Design Systems, Change Healthcare, Chartboost
Ownership status varies sharply
Cadence is an independent, publicly traded company (NASDAQ: CDNS) with roughly 13,800 employees. Change Healthcare is now part of Optum Insight within UnitedHealth Group, and Chartboost has changed hands three times — from Zynga (2021) to Take-Two (2022) to adtech company LoopMe (December 2024) — which matters for buyers assessing long-term platform stability.
Cadence Design Systems, Change Healthcare, Chartboost
Change Healthcare's scale is also its risk profile
Change Healthcare processes a large share of US medical claims, which is exactly why the February 2024 ransomware attack on it disrupted healthcare billing nationwide. Buyers evaluating claims infrastructure at this scale need to weigh that concentration risk in a way that doesn't apply to Cadence or Chartboost.
Change Healthcare
Cadence operates in an oligopoly, the other two don't
Cadence competes primarily with Synopsys and Siemens EDA in a market where nearly every major semiconductor company relies on one of a handful of vendors. Change Healthcare and Chartboost operate in markets with different competitive dynamics — healthcare claims infrastructure and mobile ad mediation, respectively.
Cadence Design Systems
| Feature | Cadence Design Systems | Change Healthcare | Chartboost |
|---|---|---|---|
| Published self-serve pricing | Unavailable | Unavailable | Limited |
| Revenue-share / programmatic pricing model | Unavailable | Unavailable | Available |
| Custom, direct enterprise sales contracts | Available | Available | Not documented |
| Feature | Cadence Design Systems | Change Healthcare | Chartboost |
|---|---|---|---|
| Semiconductor / chip and PCB design tooling | Available | Unavailable | Unavailable |
| Healthcare claims and payer-provider-pharmacy connectivity | Unavailable | Available | Unavailable |
| Mobile game ad monetization (DSP/SSP/mediation) | Unavailable | Unavailable | Available |
| Feature | Cadence Design Systems | Change Healthcare | Chartboost |
|---|---|---|---|
| Independent, publicly traded company | Available | Unavailable | Unavailable |
| Recent change of ownership via acquisition | Not documented | Available | Available |
Starting price reflects the lowest paid tier, not the full cost for every team size or usage level.
No individual plan breakdown documented yet.
No individual plan breakdown documented yet.
No individual plan breakdown documented yet.
Pros
Cons
Pros
Cons
Pros
Cons
No. They serve completely different industries — Cadence builds electronic design automation software for chip and PCB design, Change Healthcare provides claims processing and payment connectivity for healthcare payers and providers, and Chartboost is a mobile game advertising and monetization platform. None of them compete for the same buyer.
None of them do in the conventional sense. Cadence and Change Healthcare both sell through direct enterprise sales with pricing not publicly disclosed. Chartboost is free to integrate but earns revenue through ad revenue share and programmatic bidding rather than a fixed subscription fee.
No. Change Healthcare now operates as part of Optum Insight within UnitedHealth Group. It remains a major processor of US medical claims, which is also why its February 2024 ransomware attack had such a wide impact on national healthcare billing.
Chartboost is owned by adtech company LoopMe as of December 2024. Before that it passed through Zynga, which acquired it in 2021, and then Take-Two Interactive, which took ownership when it bought Zynga in 2022.
In practice they wouldn't choose between them — the decision depends entirely on the industry. A semiconductor company evaluating chip design tools would compare Cadence against Synopsys and Siemens EDA, not against Change Healthcare or Chartboost. A healthcare payer or provider would evaluate Change Healthcare against other claims-processing infrastructure, and a mobile game studio would evaluate Chartboost against other ad mediation platforms.
Read the full Cadence Design Systems review · Read the full Change Healthcare review · Read the full Chartboost review